Clearline Capital LP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 2:40 pm Purchase | 2025-12-31 | 13G | HERON THERAPEUTICS INC HRTX | Clearline Capital LP | 12,235,239 6.700% | 2,522,712 (+25.97%) | Filing |
| 2025-11-26 10:15 am Purchase | 2025-09-30 | 13G | HERON THERAPEUTICS INC HRTX | Clearline Capital LP | 9,712,527 5.300% | 9,712,527 (New Position) | Filing |